Literature DB >> 16815027

Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model.

Bhupinder P S Vohra1, Jason S Groshong, Roberto Zayas, Robert L Wollmann, Christopher M Gomez.   

Abstract

In the slow-channel syndrome (SCS) mutant acetylcholine receptors elicit calcium overload and myonuclear degeneration at the neuromuscular junction (NMJ), without muscle fiber death. Activated caspases are present at SCS motor endplates. We hypothesized that SCS represents a limited form of apoptosis. We found condensed chromatin and occasional single-strand DNA nicks in degenerating synaptic nuclei. Cleaved forms of caspases-3 and -9 were present in mouse SCS muscle homogenates and were specifically localized to NMJs. Finally, interruption of cholinergic activity by axotomy markedly reduced NMJ caspase activity and improved the morphological features of apoptosis at NMJs. These results demonstrate that in SCS processes leading to apoptosis may remain compartmentalized and reversible. Use of cysteine protease inhibitors may aid in treatment of this and other dystrophic muscle and excitotoxic disorders. Identification of extrasynaptic factors that prevent the spread of apoptosis in SCS muscle fibers may aid in developing treatments for neurological disorders characterized by excitotoxicity or apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815027     DOI: 10.1016/j.nbd.2006.04.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

1.  Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome.

Authors:  Jason S Groshong; Melissa J Spencer; Bula J Bhattacharyya; Elena Kudryashova; Bhupinder P S Vohra; Roberto Zayas; Robert L Wollmann; Richard J Miller; Christopher M Gomez
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

2.  Mechanism of neuromuscular dysfunction in Krabbe disease.

Authors:  Ludovico Cantuti-Castelvetri; Erick Maravilla; Michael Marshall; Tammy Tamayo; Ludovic D'auria; John Monge; James Jeffries; Tuba Sural-Fehr; Aurora Lopez-Rosas; Guannan Li; Kelly Garcia; Richard van Breemen; Charles Vite; Jesus Garcia; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

3.  Non-apoptotic role of caspase-3 in synapse refinement.

Authors:  Jin-Yuan Wang; Zhen-Ge Luo
Journal:  Neurosci Bull       Date:  2014-07-15       Impact factor: 5.203

4.  Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.

Authors:  Haipeng Zhu; Bula J Bhattacharyya; Hong Lin; Christopher M Gomez
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

5.  Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.

Authors:  Haipeng Zhu; Gary E Grajales-Reyes; Vivianette Alicea-Vázquez; Jose G Grajales-Reyes; KaReisha Robinson; Peter Pytel; Carlos A Báez-Pagán; Jose A Lasalde-Dominicci; Christopher M Gomez
Journal:  Exp Neurol       Date:  2014-10-23       Impact factor: 5.330

6.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

Review 7.  Therapeutic strategies in congenital myasthenic syndromes.

Authors:  Ulrike Schara; Hanns Lochmüller
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

8.  Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions.

Authors:  G E Grajales-Reyes; C A Báez-Pagán; H Zhu; J G Grajales-Reyes; M Delgado-Vélez; W F García-Beltrán; C A Luciano; O Quesada; R Ramírez; C M Gómez; J A Lasalde-Dominicci
Journal:  Pharmacogenomics J       Date:  2012-06-12       Impact factor: 3.550

Review 9.  Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models.

Authors:  José David Otero-Cruz; Carlos Alberto Báez-Pagán; Luisamari Dorna-Pérez; Gary Emanuel Grajales-Reyes; Rosaura Teresa Ramírez-Ordoñez; Carlos A Luciano; Christopher Manuel Gómez; José Antonio Lasalde-Dominicci
Journal:  P R Health Sci J       Date:  2010-03       Impact factor: 0.705

Review 10.  Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes.

Authors:  Richard G Webster
Journal:  Int J Mol Sci       Date:  2018-04-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.